Oruka Therapeutics, Inc. ORKA Accrued expenses and other liabilities
Accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s accrued expenses and other liabilities?
- Oruka Therapeutics, Inc. (ORKA) reported accrued expenses and other liabilities of $9.29M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s accrued expenses and other liabilities changed year-over-year?
- Oruka Therapeutics, Inc.'s accrued expenses and other liabilities increased by 64.0% year-over-year, from $5.66M to $9.29M.